14 investors are actively backing Leeds healthtech companies in 2026. Leeds hosts 300+ healthtech businesses generating 3B+ for the UK economy. The West Yorkshire Healthtech Investment Zone commits 160M over 10 years.
Leeds is one of the top three global locations for healthtech companies. The region holds one third of all UK healthtech businesses, and investors know it.
Don't pitch Leeds healthtech investors without NHS proof points. Little Journey closed a 6M Series A backed by Mercia, Octopus, and Foresight - all three wanted NHS deployment data before committing.
Set up an Ellty data room with your clinical validation data, regulatory status, and financial model before approaching any Leeds investor. Digital health investors request due diligence materials fast.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| Mercia Ventures | Regional VC and NPIF II | 500K to 10M | Healthtech, AI, Yorkshire | merciaventures.co.uk |
| Foresight Group | Regional PE and VC | 300K to 2M | Leeds healthtech, West Yorkshire | foresight.group |
| Octopus Ventures | Growth VC | 1M to 15M | Healthtech, digital health, UK-wide | octopusventures.com |
| BGF | Growth equity | 3M to 10M | Healthtech scale-ups, Yorkshire | bgf.co.uk |
| Par Equity | EIS fund and angel network | 200K to 2M | UK healthtech and deep tech | parequity.com |
| NPIF II / British Business Bank | Government-backed fund | 100K to 5M | Yorkshire healthtech, all sectors | british-business-bank.co.uk |
| Propel West Yorkshire | Accelerator and fund | Non-dilutive support | West Yorkshire healthtech innovators | nexusleeds.co.uk |
| Health Innovation Leeds Incubator | Incubator and programme | 2M fund, non-dilutive support | Leeds healthtech startups and SMEs | healthinnovationleeds.com |
| DSW Ventures | Early-stage VC | Up to 2M | Health software, AI, Yorkshire | dsw.vc |
| SFC Capital | SEIS and EIS fund | 100K to 300K | UK healthtech, SEIS/EIS | sfccapital.com |
| Haatch | Early-stage VC | Pre-seed to Series A | Healthtech, AI, UK-wide | haatch.com |
| West Yorkshire Combined Authority | Regional investment body | Non-dilutive grants and funds | Yorkshire healthtech, Investment Zone | westyorks-ca.gov.uk |
| Innovate UK | Government grants | 25K to 2M non-dilutive | Leeds healthtech, R&D | ukri.org |
| Ascension Ventures | Seed VC | Up to 2M | Healthtech, impact, UK-wide | ascension.vc |
Build an Ellty data room. See which investors open your clinical data.
Start free 14-day trialLeeds healthtech investors back digital health platforms, medical devices, AI diagnostics, and NHS-facing tools. They differ from generalist VCs by expecting NHS validation or a clinical advisory board before seed.
Most Leeds healthtech deals involve a specialist VC alongside regional capital. Little Journey's 6M Series A combined Mercia, Octopus, Foresight, and Par Equity - four different investor types in one round. That's common in Leeds where capital stacks are layered.
Leeds Teaching Hospitals is one of the UK's largest NHS trusts with 2.2M patient contacts per year. Proximity to that data pipeline changes what investors expect from founders here.
Read how Oxford healthtech investors compare in terms of the academic spinout focus vs the NHS-led approach in Leeds.
We are proud to be partnering with Leeds Teaching Hospitals NHS Trust, one of the UK's largest trusts, to use innovation to improve patient care. The combination of clinical data access and investor support in Leeds is unmatched outside London.
Mercia co-led Little Journey's 6M Series A in 2025, a Leeds-based paediatric healthtech used in 49 NHS hospitals. Mercia manages the 100M NPIF II Equity Yorkshire and Humber mandate and has 19 university partnerships. They are the first institutional call for Leeds healthtech founders at seed and Series A.
Use Ellty to share your pitch materials with Mercia before first contact. Clinical validation data and regulatory status should be in your data room from day one.
Foresight invested 300K into Little Journey's paediatric healthtech platform in July 2025 as part of its closing 6M Series A. Foresight manages a 20M West Yorkshire SME Investment Fund and a dedicated deep tech fund. They're the right investor for Leeds healthtech founders raising under 2M.
Octopus Ventures co-led Little Journey's 6M Series A in 2025 and is one of the UK's most active healthtech VCs. They've backed 170+ companies and focus on health, fintech, and deep tech. Octopus writes 1M to 15M checks and prioritises companies with strong NHS adoption.
BGF deployed 416M in 2025 and is actively building its Yorkshire portfolio. They back healthtech scale-ups with 1M+ ARR and an established NHS or private healthcare customer base. BGF's Yorkshire team is led by Partner Chris Boyes, who was promoted in 2025.
Par Equity is a Scottish EIS and angel investor that backed Little Journey's 6M Series A in 2025. They invest in high-growth UK technology companies with tickets from 200K to 2M. Par Equity looks for founders with deep domain expertise and a defensible market position.
Use Ellty to send a trackable link to your deck when reaching out to Par Equity. They review a high volume of applications and track which materials get opened.
Use Ellty to see which investors spend time on your clinical validation data.
Start free 14-day trialNPIF II has deployed 180M+ into 315+ Northern businesses. In Yorkshire, the fund backs healthtech companies via Mercia (equity up to 5M) and BEF (debt 25K to 100K). NPIF II is the default institutional funding route for NHS-facing Leeds healthtech companies.
Propel West Yorkshire launched its second healthtech cohort at Nexus Leeds on April 30, 2026, backed by 4.5M from West Yorkshire Combined Authority. The programme supports 30 innovators across AI, mental health, and patient pathway transformation. It's the fastest route from idea to investor-ready for Leeds healthtech founders.
The 2M Health Innovation Leeds Incubator launched in November 2025, led by Nexus at the University of Leeds with Leeds Beckett University and Leeds Teaching Hospitals NHS Trust. It provides structured support to 70+ regional healthtech businesses focused on NHS adoption, regulation, and product development.
DSW Ventures has a Leeds office and backs health software and AI companies alongside their general software mandate. They invest up to 2M into Yorkshire founders with product-market fit. DSW recently backed Diabetalabs, a health AI startup in their portfolio.
Read the best investor relations software guide before managing parallel outreach to DSW, Mercia, and Foresight simultaneously. Pipeline tracking is critical in a competitive raise.
SFC Capital backs SEIS and EIS qualifying healthtech founders with 100K to 300K per deal. They've invested in 580+ companies and move faster than most institutional VCs. SFC Capital is the right first institutional investor for pre-revenue Leeds healthtech companies.
Haatch backs applied AI and healthtech at pre-seed with 21 investments in the last 12 months. They co-invest with NPIF II-backed funds on Yorkshire deals. Haatch is the fastest route to pre-seed capital for Leeds founders who haven't yet connected with Mercia.
WYCA manages the 160M West Yorkshire Healthtech and Digital Tech Investment Zone, expected to leverage 220M+ in public and private investment over five years. WYCA funded both the Propel Healthtech programme and the Health Innovation Leeds Incubator. This is non-dilutive capital that every Leeds healthtech founder should apply for before approaching VCs.
Innovate UK's AI in Health and Social Care programme funded multiple Yorkshire companies in 2025. Leeds Teaching Hospitals launched an AI Lab in August 2025 backed by Innovate UK partnerships. Non-dilutive grants from 25K to 2M validate your technology before VCs ask for it.
Ascension Ventures is one of the UK's most active seed VCs with 180+ portfolio companies. They back healthtech, impact tech, and B2B SaaS across the UK with an active Ascension Syndicate for co-investment. Ascension writes pre-seed and seed checks where larger funds won't.
Apply to Propel West Yorkshire before approaching any VC. Programme membership signals NHS readiness and gives you investor introductions without cold outreach. The third cohort will open applications later in 2026.
Don't skip the Health Innovation Leeds Incubator if you're pre-seed. The 70-company programme connects you with Leeds Teaching Hospitals data access and investor introductions. That's worth more than most seed checks at the early stage.
Use Ellty to share your clinical data room with investors. Send trackable links and see which investors open your MHRA status and NHS deployment docs.
Most Leeds healthtech investors won't commit to a pre-revenue company without an NHS letter of intent or signed pilot agreement. Leeds Teaching Hospitals, St James's, and Harrogate NHS trust are all accessible for pilots. Get one of them on paper before you raise.
Don't pitch AI diagnostic tools without CE marking or UKCA certification data. Post-Brexit regulatory status is the first thing Mercia and Octopus check for med-tech investments. Know your MHRA pathway.
The West Yorkshire Health Tech Cluster holds regular investor meetings. Their annual conference puts you directly in front of WYCA funders, NHS innovation leads, and regional VCs. The cluster's Driving the Future of Innovation event launched the Health Innovation Leeds Incubator in November 2025.
Leeds Digital's healthtech events connect founders with Mercia, Foresight, and BGF through quarterly networking. HealthTech Leeds has profiled 80+ companies in the ecosystem with investor contact data.
Four steps tailored to how Yorkshire digital health VCs evaluate founders.
You know the investors. Now organise your clinical materials before first contact.


